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More objective diagnoses of venous thromboembolism?
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The clinical diagnosis of deep venous thrombosis is non-specific, i.e. suffers from a large number of
false-positive diagnoses. Therefore, the use of objective tests is emphasized. We have investigated retrospec-
tively the increase, if any, in the use of objective tests over a three year period in the Leiden area
(1986-1989).
We found that the percentage of patients on whom objective tests were used was more than doubled, from
21% to 55%; this increase was accornpanied by a 29% decrease in the incidence of venous thromboembolic
disease. These opposing trends are to be expected if more objective tests are used. Neth J Med
1991;38:246-248.
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Introduction
A major problem in the diagnosis of venous
thromboembolism (deep-vein thrombosis and
pulmonary embohsm) is that the clinical diagnosis
is far from accurate It has been reported that the
Proportion of patients mcorrectly labelled on
clinical grounds with these diagnoses (false posi-
tives) vanes from 50 to 70% [1,2] Thus, if we
rehed on clinical diagnosis only, a large number of
patients would be treated with anticoagulants un-
necessanly, entaihng risk of bleedmg and high
costs [3] In April 1986 a consensus development
meetmg was held in The Netherlands on the use
of diagnostic tests for venous thromboembolism,
m which the participants concluded that objective
diagnostic tests should be employed m all patients
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in whom venous thromboembolism is suspected
[4]·
We performed two studies to find out about the
increase, if any, in the use of objective tests smce
the consensus meetmg in 1986
Materials and Methods
The first study mcluded 50 subjects who were
randomly selected (by means of a random number
table) from all consecutive patients (N = 404) re-
ferred because of a first venous thrombotic event
to the Leiden Thrombosis Service m 1986. As
described elsewhere [5], each Thrombosis Service
m The Netherlands serves a well-defmed geo-
graphical area, which, for the Leiden Thrombosis
Service, has about 450,000 inhabitants A ques-
tionnaire was sent to the patient's physician, with
a request for Information on how the diagnosis
had been made. A second, identical study was
performed three years later Seventy subjects were




ming a third request by telephone for Information
to all non-responding physicians of the second
study. After these requests the response increased
to 59 subjects (95%). In 36 of them (61%) objective
diagnostic tests were used. This result indicates
that the non-responders were not necessarily the
physicians who relied only on the clinical presen-
tation.
Discussion
We found an increased use of objective di-
agnostic tests for venous thromboembolism (by
34%) accompanied by a decrease in the number of
registrations for anticoagulant treatment after a
first venous thrombotic event in the Leiden
Thrombosis Service (by 29%), in a period of three
years. These opposing trends are to be expected if
more objective tests are used by physicians who
see the patient first. Presumably this will lead to
fewer patients being treated unnecessarily.
In addition, these data provide ever better
estimates of the incidence of diagnosed venous
thromboembolic disease: 1986: 90 per 100,000 per
year; 1987: 81 per 100,000 per year; 1988: 67 per
100,000 per year; and 1989: 64 per 100,000 per
year. Since virtually all patients with a diagnosis
of venous thrombosis or pulmonary embolism are
treated with oral anticoagulants and this treat-
ment is always controlled by the Leiden Thrombo-
sis Service (unless the patient dies in the hospital
shortly after the event), these estimates are rea-
sonably accurate. With further introduction of
objective diagnostic methods we expect that the
true incidence of symptomatic venous thrombo-
embolism will prove to be in the order of 50 per
100,000 per year. This educated guess was calcu-
lated by adding all objectively diagnosed patients
to 50% of the remaining referred patients, since
half of these are expected to be false positives.
Subsequently, the total number of patients is di- '
vided by the total population in the Leiden region.
When we apply this calculation to our results of
1986 and 1989, strikingly similar estimates result:
54 per 100,000 and 49 per 100,000, respectively.
In conclusion, we think a growing consensus is
developing in the diagnosis of venous thromboem-
bolism. While it is impossible to ascribe this effect
to the 1986 consensus meeting with certainty, a
beneficial influence is highly likely.
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